Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Welbutol (Ethambutol) 400 mg
Welbutol (Ethambutol) 400 mg is a potent antimycobacterial medication used in the treatment of tuberculosis (TB). As a frontline drug, it plays a critical role in multidrug regimens, preventing resistance and ensuring effective disease management.
Uses of Welbutol (Ethambutol) 400 mg
Indicated for active tuberculosis treatment in adults and children
Used in combination with other first-line anti-TB medications
Effective against Mycobacterium tuberculosis, including drug-sensitive strains
Benefits of Welbutol (Ethambutol) 400 mg
Inhibits mycobacterial growth, reducing bacterial load
Prevents drug resistance when used in combination therapy
Well-tolerated with minimal gastrointestinal side effects
Enhances treatment success rates when administered as per guidelines
Mechanism of Action of Welbutol (Ethambutol) 400 mg
Ethambutol acts by inhibiting arabinosyl transferase, an enzyme essential for mycobacterial cell wall biosynthesis. This disruption weakens the bacterial cell wall, impairing bacterial replication and ultimately leading to pathogen elimination. Regular ophthalmologic evaluation is recommended to monitor potential visual disturbances.